Evidence map›Paper›PMID 35328050›Full record

ReviewGenes2022

Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.

Michele Callea, Diego Martinelli, Francisco Cammarata-Scalisi, Chiara Grimaldi, Houweyda Jilani, Piercesare Grimaldi, Colin Eric Willoughby, Antonino Morabito

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Case report: A novel mutation inFrontiers in oncology · 2023
    Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Michele CalleaPediatric Dentistry and Special Dental Care Unit, Meyer Children's University Hospital, 50139 Florence, Italy.
Diego MartinelliUnit of Metabolism, Bambino Gesù Children's Research Hospital, Piazza Sant'Onofrio, 4, 00165 Rome, Italy.
Francisco Cammarata-ScalisiServicio de Pediatría, Hospital Regional de Antofagasta, Antofagasta 1240835, Chile.
Chiara GrimaldiDepartment of Pediatric Surgery, Meyer Children's Hospital, Viale Gaetano Pieraccini 24, 50139 Florence, Italy.ORCID 0000-0003-3551-9286
Houweyda JilaniGenetic Department, Mongi Slim Hospital, Marsa 2046, Tunisia.ORCID 0000-0002-7433-0294
Piercesare GrimaldiDepartment of Public Health and Pediatric Sciences, University of Torino, 10125 Torino, Italy.
Colin Eric WilloughbyGenomic Medicine, Biomedical Sciences Research Institute, Ulster University, Coleraine Campus, Coleraine BT52 1SA, UK.ORCID 0000-0002-1246-4166
Antonino MorabitoDepartment of Pediatric Surgery, Meyer Children's Hospital, Viale Gaetano Pieraccini 24, 50139 Florence, Italy.ORCID 0000-0002-5323-3620
Meyer Children's Hospital · ITBambino Gesù Children's Hospital · ITHospital Regional de Antofagasta · CLTunis University · TNUniversity of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyskeratosis congenital (DC) is the first genetic syndrome described among telomeropathies. Its classical phenotype is characterized by the mucocutaneous triad of reticulated pigmentation of skin lace, nail dystrophy and oral leukoplakia. The clinical presentation, however, is heterogeneous and serious clinical complications include bone marrow failure, hematological and solid tumors. It may also involve immunodeficiencies, dental, pulmonary and liver disorders, and other minor complication. Dyskeratosis congenita shows marked genetic heterogeneity, as at least 14 genes are responsible for the shortening of telomeres characteristic of this disease. This review discusses clinical characteristics, molecular genetics, disease evolution, available therapeutic options and differential diagnosis of dyskeratosis congenita to provide an interdisciplinary and personalized medical assessment that includes family genetic counseling.

Indexed as

Dyskeratosis CongenitaNails, MalformedHumansLeukoplakia, OralRare DiseasesTelomereclinicdyskeratosis congenitaetiologytelomeropathiestreatment

Identifiers

PMID35328050
PMCPMC8953471
OpenAlexW4220691423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.